New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, ...
The Robakowo facility will continue supplying medicines and vaccines to 13 countries, supported by automation, ...
Cannara Biotech (TSX:LOVE) released third-quarter financial results and hosted an earnings call on Wednesday. Read the ...
Oxford Biomedica announced on Thursday that it has signed an agreement to provide process development and AAV GMP ...
Recently, ACROBiosystems has officially received the 'Material Suitability Confirmation for Regenerative Medicine Products' (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices ...
Perth biotech Syngenis Labs has banked an oversubscribed $4M pre-IPO raise to expand its AI-powered RNA platform and ...
HRV Pharma introduces RIKO, India's first AI-native pharmaceutical operating system: Our Bureau, Mumbai Thursday, July 16, 2026, 14:15 Hrs [IST] HRV Pharma, the global, virtual ph ...
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...
In July 2026, Arovella Therapeutics announced a collaboration with Charles River Laboratories International to provide GMP ...
Cannara Biotech Inc. (“Cannara ”, the “Company ”, “us ” or “we ”) (OTCQX: LOVFF) , a vertically integrated producer of ...
North American researchers now have access to affordable, high-sensitive, fast, and low sample volume ELISA kits We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results